Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.49 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3378961 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL16518811 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL16360067 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL10519642 | 0.86 | ALDH1A1 (0.65) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL8070812 | 0.86 | ALDH1A1 (0.75) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL15958908 | 0.86 | ALDH1A1 (0.56) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL13990828 | 0.85 | ALDH1A1 (0.69) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL526338 | 0.85 | ALDH1A1 (0.69) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL12715390 | 0.85 | ALDH1A1 (0.69) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL12188228 | 0.85 | ALDH1A1 (0.46) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 620 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873605-B2 | Liquid-state temporary reinforcing material, preparation method therefor and application thereof | SHANGHAI UNIVERSITY (CN) | 2024-01-16 | — | — | US | claimed |
| EP-3690134-A1 | LIQUID-STATE TEMPORARY REINFORCING MATERIAL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai University (CN) | 2020-08-05 | — | — | EP | claimed |
| US-20200217009-A1 | LIQUID-STATE TEMPORARY REINFORCING MATERIAL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI UNIVERSITY (CN) | 2020-07-09 | — | — | US | claimed |
| US-8569383-B2 | Utilization of rhinologically active substances | SYMRISE AG (DE) | 2013-10-29 | — | — | US | claimed |
| EP-2014273-A1 | Use of methyl methyl ether and another ether to provide a feeling of cleanliness and purity | Symrise GmbH & Co. KG (DE) | 2009-01-14 | — | — | EP | claimed |
| EP-1341512-B1 | RHINOLOGICAL AGENTS | SYMRISE GMBH & CO KG (DE) | 2008-12-31 | — | — | EP | claimed |
| US-7456308-B2 | Grignard processes with improved yields of diphenylchlorosilanes as products | DOW CORNING CORPORATION (US) | 2008-11-25 | — | — | US | claimed |
| US-20080274064-A1 | UTILIZATION OF RHINOLOGICALLY ACTIVE SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2008-11-06 | — | — | US | claimed |
| EP-1973422-A1 | COMPOSITIONS PROVIDING A HEATING SENSATION FOR ORAL OR DERMAL DELIVERY | Cadbury Adams USA LLC (US) | 2008-10-01 | — | — | EP | claimed |
| US-7414079-B2 | Utilization of rhinologically active substances | SYMRISE GMBH & CO. KG (DE) | 2008-08-19 | — | — | US | claimed |
| WO-2007126430-A1 | COMPOSITIONS PROVIDING A HEATING SENSATION FOR ORAL OR DERMAL DELIVERY | CADBURY ADAMS USA LLC (US) | 2007-11-08 | — | — | WO | claimed |
| US-20060040218-A1 | Terpene ether solvents | WYATT MARION F | 2006-02-23 | — | — | US | claimed |
| US-20050027017-A1 | Rhinologically active substances | SYMRISE AG (DE) | 2005-02-03 | — | — | US | claimed |
| EP-1341512-A1 | RHINOLOGICAL AGENTS | HAARMANN & REIMER GMBH (DE) | 2003-09-10 | — | — | EP | claimed |
| US-20020120014-A1 | Rhinologically active substances | HAARMANN & REIMER GMBH (DE) | 2002-08-29 | — | — | US | claimed |
| WO-2002041861-A1 | RHINOLOGICAL AGENTS | HAARMANN & REIMER GMBH (DE) | 2002-05-30 | — | — | WO | claimed |
| US-11914294-B2 | Positive resist composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11914294-B2 | Positive resist composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
| WO-2002041861-A1 | RHINOLOGICAL AGENTS | HAARMANN & REIMER GMBH (DE) | 2002-05-30 | — | — | WO | disclosed |
| US-5437331-A | Using an enzyme | THE WESTERN COMPANY OF NORTH AMERICA (US) | 1995-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020120014-A1 | Rhinologically active substances | TRPV1, TRPA1, CRH | ALDH1A1 744/4885LMNA 2951/4885KDM4E 2239/4885 |
| US-20080274064-A1 | UTILIZATION OF RHINOLOGICALLY ACTIVE SUBSTANCES | MRGPRX4, HCRTR1, TRPV1 | ALDH1A1 466/4885LMNA 2706/4885KDM4E 3257/4885 |
| US-20050027017-A1 | Rhinologically active substances | TRPV1, TRPA1, CRH | ALDH1A1 744/4885LMNA 2951/4885KDM4E 2239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.